Nanoparticles can be functionalized with specific ligands that bind to receptors on the platelet surface. This targeting ensures that the nanoparticles interact specifically with platelets, reducing off-target effects and increasing the efficacy of the therapeutic agents they carry. For instance, peptide ligands or antibodies can be attached to the nanoparticles to target platelet receptors like GP IIb/IIIa.
